| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |